all the following statements about hybridoma technology are true except :
Hybridoma technology is used to produce monoclonal antibodies. The process involves fusing B cells from an immunized animal with myeloma cells to create hybrid cells that can proliferate indefinitely and secrete antibodies. The key steps include immunization, cell fusion using polyethylene glycol (PEG), selection with HAT medium to eliminate unfused cells, and screening for antibody production.
The question asks which statement is false. Common misconceptions or incorrect statements might include things like not requiring immunization, using different cell types, incorrect selection methods, or failure to produce monoclonal antibodies. Let's think of possible wrong options. For example, if an option says "Hybridoma cells are immortal without myeloma fusion," that's incorrect because the myeloma cells provide the immortality. Another wrong point could be using a different medium like HEPES instead of HAT for selection. Also, if someone claims that hybridomas are produced by fusing T cells instead of B cells, that's wrong.
Assuming the correct answer is one of these, I need to structure the explanation. The core concept is hybridoma technology for monoclonal antibodies. The correct answer would be the false statement, so I need to explain why the others are true. For each wrong option, I have to point out the error. The clinical pearl would emphasize the key steps in hybridoma production.
Wait, the user's correct answer is missing. Since the original problem had options A-D and the correct answer is one of them, but the user didn't specify, I'll have to proceed with the assumption that the correct answer is, say, option C. Let me outline the sections as per the user's instructions.
First, the core concept: Hybridoma tech uses B cells fused with myeloma cells to make monoclonal antibodies. The HAT medium selects for hybridomas. Now, for the correct answer explanation, maybe the false statement is something like "Hybridoma cells are selected using a medium without thymidine," which is incorrect because HAT includes hypoxanthine, aminopterin, and thymidine. The wrong options would each have specific errors. The clinical pearl would be the essential steps: immunization, fusion, HAT selection, screening.
I need to make sure the explanation is concise and fits within the character limit. Let me draft each section step by step, ensuring all required parts are included.
**Core Concept**
Hybridoma technology involves fusing **B lymphocytes** from immunized animals with **myeloma cells** to produce **monoclonal antibodies (mAbs)**. Key steps include immunization, cell fusion via **polyethylene glycol (PEG)**, and selection in **HAT medium** to eliminate unfused cells. Hybridomas are screened for antigen-specific antibody production.
**Why the Correct Answer is Right**
The incorrect statement likely describes a flawed understanding of hybridoma selection. For example, if an option claims hybridomas are selected without **HAT medium**, this is false.